» Articles » PMID: 38163085

Promotes Intestinal Epithelial IL-18 Production Through Activation of the HIF1α Pathway

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2024 Jan 1
PMID 38163085
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Intestinal epithelial cells produce interleukin-18 (IL-18), a key factor in promoting epithelial barrier integrity. Here, we analyzed the potential role of gut bacteria and the hypoxia-inducible factor 1α (HIF1α) pathway in regulating mucosal expression in inflammatory bowel disease (IBD).

Methods: Mucosal samples from patients with IBD ( = 760) were analyzed for bacterial composition, levels and HIF1α pathway activation. Wild-type Caco-2 and CRISPR/Cas9-engineered Caco-2--null cells were cocultured with in a "Human oxygen-Bacteria anaerobic" system and analyzed by RNA sequencing.

Results: Mucosal mRNA levels correlated positively with the abundance of mucosal-associated butyrate-producing bacteria, in particular , and with HIF1α pathway activation in patients with IBD. HIF1α-mediated expression of , either by a pharmacological agonist (dimethyloxallyl glycine) or , was abrogated in Caco-2--null cells.

Conclusion: Butyrate-producing gut bacteria like regulate mucosal expression in a HIF1α-dependent manner that may aid in mucosal healing in IBD.

Citing Articles

Biological characteristics, immune infiltration and drug prediction of PANoptosis related genes and possible regulatory mechanisms in inflammatory bowel disease.

Zhang M, Liu T, Luo L, Xie Y, Wang F Sci Rep. 2025; 15(1):2033.

PMID: 39814753 PMC: 11736032. DOI: 10.1038/s41598-024-84911-1.


Bacterial extracellular vesicles at the interface of gut microbiota and immunity.

Melo-Marques I, Cardoso S, Empadinhas N Gut Microbes. 2024; 16(1):2396494.

PMID: 39340209 PMC: 11444517. DOI: 10.1080/19490976.2024.2396494.


Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery.

Xiao J, Guo X, Wang Z Front Immunol. 2024; 15:1385907.

PMID: 38605960 PMC: 11007100. DOI: 10.3389/fimmu.2024.1385907.

References
1.
Hu S, Uniken Venema W, Westra H, Vich Vila A, Barbieri R, Voskuil M . Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease. Nat Commun. 2021; 12(1):1122. PMC: 7892863. DOI: 10.1038/s41467-021-21458-z. View

2.
Nowarski R, Jackson R, Gagliani N, de Zoete M, Palm N, Bailis W . Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis. Cell. 2015; 163(6):1444-56. PMC: 4943028. DOI: 10.1016/j.cell.2015.10.072. View

3.
Lapiere A, Geiger M, Robert V, Demarquay C, Auger S, Chadi S . Prophylactic treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease. Gut Microbes. 2020; 12(1):1-15. PMC: 7524396. DOI: 10.1080/19490976.2020.1812867. View

4.
Synnestvedt K, Furuta G, Comerford K, Louis N, Karhausen J, Eltzschig H . Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest. 2002; 110(7):993-1002. PMC: 151145. DOI: 10.1172/JCI15337. View

5.
Manor O, Dai C, Kornilov S, Smith B, Price N, Lovejoy J . Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020; 11(1):5206. PMC: 7562722. DOI: 10.1038/s41467-020-18871-1. View